Arcellx
Intelligent and adaptive cell therapies to treat the complexity of human disease.
Launch date
Employees
Market cap
CAD5.5b
Enterprise valuation
CAD4.9b (Public information from Sep 2024)
Share price
$85.43 ACLX
Gaithersburg Maryland (HQ)
Authorizing premium user...